These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38407745)
1. Dexmedetomidine alleviates Hypoxia/reoxygenation-induced mitochondrial dysfunction in cardiomyocytes via activation of Sirt3/Prdx3 pathway. Tan Q; Dong W; Wang Q; Gao L Daru; 2024 Jun; 32(1):189-196. PubMed ID: 38407745 [TBL] [Abstract][Full Text] [Related]
2. SIRT3-mediated deacetylation of PRDX3 alleviates mitochondrial oxidative damage and apoptosis induced by intestinal ischemia/reperfusion injury. Wang Z; Sun R; Wang G; Chen Z; Li Y; Zhao Y; Liu D; Zhao H; Zhang F; Yao J; Tian X Redox Biol; 2020 Jan; 28():101343. PubMed ID: 31655428 [TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine Ameliorates Cardiac Ischemia/Reperfusion Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT3 Pathway. He H; Liu P; Li P Drug Des Devel Ther; 2023; 17():3205-3218. PubMed ID: 37908314 [TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling. Yang FY; Zhang L; Zheng Y; Dong H Bioengineered; 2022 Jan; 13(1):1377-1387. PubMed ID: 34974801 [TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine Attenuates Cellular Injury and Apoptosis in H9c2 Cardiomyocytes by Regulating p-38MAPK and Endoplasmic Reticulum Stress. Zhu Z; Ling X; Zhou H; Zhang C; Yan W Drug Des Devel Ther; 2020; 14():4231-4243. PubMed ID: 33116411 [TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway. Zhang Y; Zhao Q; Li X; Ji F Mol Cell Biochem; 2021 Jul; 476(7):2803-2812. PubMed ID: 33725228 [TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis. Wang L; Liu J; Wang Z; Qian X; Zhao Y; Wang Q; Dai N; Xie Y; Zeng W; Yang W; Bai X; Yang Y; Qian J Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462 [TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats. Yu W; Lyu J; Jia L; Sheng M; Yu H; Du H Oxid Med Cell Longev; 2020; 2020():7385458. PubMed ID: 34493950 [TBL] [Abstract][Full Text] [Related]
9. Sappanone A alleviates hypoxia/reoxygenation-induced cardiomyocytes injury through inhibition of mitochondrial apoptosis and activation of PI3K-Akt-Gsk-3β pathway. Shi X; Tao G; Ji L; Tian G Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095825 [TBL] [Abstract][Full Text] [Related]
10. Involvement of GPR30 in protection effect of Dexmedetomidine against myocardial ischemia/reperfusion injury in rat via AKT pathway. Shao Z; Shen Q; Kong M; Ni H; Hou X Acta Biochim Pol; 2021 Feb; 68(1):119-126. PubMed ID: 33629579 [TBL] [Abstract][Full Text] [Related]
11. Glycine Protects H9C2 Cardiomyocytes from High Glucose- and Hypoxia/Reoxygenation-Induced Injury via Inhibiting PKC Zhang Y; Su W; Zhang Q; Xu J; Liu H; Luo J; Zhan L; Xia Z; Lei S J Diabetes Res; 2018; 2018():9502895. PubMed ID: 29850613 [TBL] [Abstract][Full Text] [Related]
12. Muscone alleviates myocardial ischemia-reperfusion injury via inhibition of oxidative stress and enhancement of SIRT3. Wei CJ; Hua F; Chen YH; Zhang ZW; Shen ZY J Biol Regul Homeost Agents; 2021; 35(1):85-96. PubMed ID: 33480219 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol Reestablishes Mitochondrial Quality Control in Myocardial Ischemia/Reperfusion Injury through Sirt1/Sirt3-Mfn2-Parkin-PGC-1α Pathway. Zheng M; Bai Y; Sun X; Fu R; Liu L; Liu M; Li Z; Huang X Molecules; 2022 Aug; 27(17):. PubMed ID: 36080311 [TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis. Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878 [TBL] [Abstract][Full Text] [Related]
15. Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway. Ding H; Han R; Chen X; Fang W; Liu M; Wang X; Wei Q; Kodithuwakku ND; Li Y Molecules; 2016 May; 21(6):. PubMed ID: 27248986 [TBL] [Abstract][Full Text] [Related]
17. Aqueous extract of Cortex Dictamni protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress and apoptosis by PI3K/Akt signaling pathway. Li L; Zhou Y; Li Y; Wang L; Sun L; Zhou L; Arai H; Qi Y; Xu Y Biomed Pharmacother; 2017 May; 89():233-244. PubMed ID: 28231545 [TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms. Cai S; Liu Y; Cheng Y; Yuan J; Fang J J Clin Lab Anal; 2022 Jul; 36(7):e24119. PubMed ID: 34882841 [TBL] [Abstract][Full Text] [Related]
19. Sitagliptin mitigates hypoxia/reoxygenation (H/R)-induced injury in cardiomyocytes by mediating sirtuin 3 (SIRT3) and autophagy. Yang M; Xi N; Gao M; Yu Y Bioengineered; 2022 May; 13(5):13162-13173. PubMed ID: 35635037 [TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine Protects Cardiomyocytes against Hypoxia/Reoxygenation Injury by Suppressing TLR4-MyD88-NF- Gao JM; Meng XW; Zhang J; Chen WR; Xia F; Peng K; Ji FH Biomed Res Int; 2017; 2017():1674613. PubMed ID: 29359143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]